Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Loss of muscle mass and increased fibrosis characterize both sarcopenia of aging and muscular dystrophy. Research is increasingly showing that these two conditions also share several pathophysiological mechanisms, including mitochondrial dysfunction, increased apoptosis, abnormal modulation of autophagy, decline in satellite cells, increased generation of reactive oxygen species, and abnormal regulation of signaling and stress response pathways. This Research Topic will cover several mechanisms involved in aging and dystrophic sarcopenia and explore the therapeutic potential of various strategies for intervention.

Aging sarcopenia --- muscular dystrophy --- Autophagy --- Mitochondrial dysfunction --- Apoptosis --- satellite cells --- skeletal muscle --- muscle imaging --- Animal Models --- therapy

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Innovations in molecular biology are allowing neuroscientists to study the brain with unprecedented resolution, from the level of single molecules to integrated gene circuits. Chief among these innovations is the CRISPR-Cas genome editing technology, which has the precision and scalability to tackle the complexity of the brain. This Colloque Médecine et Recherche has brought together experts from around the world that are applying genome editing to address important challenges in neuroscience, including basic biology in model organisms that has the power to reveal systems-level insight into how the nervous system develops and functions as well as research focused on understanding and treating human neurological disorders.

CRISPR --- genetic engineering --- DNA --- double-strand breaks --- Parkinson's disease --- Huntington's disease --- Rett syndrome --- muscular dystrophy